{"name":"ATXA Therapeutics Limited","slug":"atxa-therapeutics-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNY3JKS19LMVBhd056MjlTMTFQTnNsb3B2UVpHVXNfcTBNWEdKNlgyblU5dFZNaG5aV2c2RXJXeGYwRmJ3b01DSFNicE5TX0Z1TnRqOGlEOTFheGp5OUJ4QkRpeHhtNXZNb1FvX2dfci1PTjFZMWJwdmprMEY0Z04zdU5RX1BrbTRkaF80ZXBvdGREY3lsTWVGOU9tOVdubGZUVGtMcGJNcTNtUTY3WGdlZmxmem5aWndC?oc=5","date":"2025-03-31","type":"trial","source":"Business Post","summary":"ATXA’s journey to trial a new lung disease treatment enters critical phase - Business Post","headline":"ATXA’s journey to trial a new lung disease treatment enters critical phase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQeHhISHVyb2Z5d2h0aGoyZW4takJhLTlQaDlYbFFlaTRvMnBrN3h6cEttemhWelM0SzRkRFlzVlkzTkdET1dqb2xZcVdjZ0pKWGZIVnd0QnBDRHJjN0J3WXZmaWRpU0g4VndCYk9zSE94dF80VWNWX01MYXpJci02SFozdHlOdlR2TkM0ckNpdjBzVHE5U2hVUzc0U0dMODBXZkNYY08xOFh1OE53eWRRYi03cUIwQlh3d0JvTU41djhNMm9Mc3hBelZldmRETjlQd3ptNmlkY2RuQm9zR1F4WlMzeVQyUnhxeDdBSUNSbjRJX1NLVjI0ZEs0bmY3dWh4dDd1TFZKbjlpNTlIeXdqdm9PWG1mS3hEMTNTTmRjZw?oc=5","date":"2025-01-20","type":"trial","source":"GlobeNewswire","summary":"Advancements in Ocular Hypertension Clinical Trial Pipeline - GlobeNewswire","headline":"Advancements in Ocular Hypertension Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-07-19","type":"pipeline","source":"PR Newswire","summary":"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer B","headline":"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Ba","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOdnhRenNVZFFNeU9IOFVZTURuMDRLa3M3NlYyenJ6TXYxbi1DNjlyQ1ctZ0NGOWZUaDJHN3N1YlVTekdGN3oyQl9JRE9fNlJwM0lXSWxfYXRRYm0wRkdnZEdFWlBCNXA2M2g4ckFVRnlLQjRhUVNXSllaMVpwTjJ4TkZkRXlSM21mbC1FcUJ2a0FiY1czUVprTjhJVHU?oc=5","date":"2021-09-13","type":"pipeline","source":"CORDIS","summary":"New hope for pulmonary arterial hypertension patients | PAH-HOPE Project | Results in Brief | H2020 - CORDIS","headline":"New hope for pulmonary arterial hypertension patients | PAH-HOPE Project | Results in Brief | H2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPeEluZ3ZnOWthczJSR2tFS1ZwMDM3bFNrcVRPbEhybllLamdtbXI1WnVvZXhJQXBWOGpIYjJVMThWUWRERGdSNUNYemd0bWluQnJUbHlzd1l0WTZwNENJTW4waFBQbF9tZkdsd3FPbGJIRGhxN0JpRTdnUU1wRk1DYTZBaVU3cEFDT3pDSkVTd0c5NkN3eVlYMnc4XzJyeWlvQTliN1VUVjNRaS14UmNReg?oc=5","date":"2020-12-18","type":"pipeline","source":"StartUs Insights","summary":"5 Top Pulmonology Drug Solutions Impacting the Pharma Sector - StartUs Insights","headline":"5 Top Pulmonology Drug Solutions Impacting the Pharma Sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5iUlpTTXZKcXoxS1ZFTnlrdnlNREIwcFpITG80OFpta2ptekI3eUNsWURHNXc0QUo2NDlWNVNMcjlFdkswSThxQjNyM0pkN1p3dnVpel9uS3RLVXk3V0w5NTVoeXlNS0ZwdVZEb1daY01OT0hiNDFfbldWZ2I?oc=5","date":"2019-05-01","type":"pipeline","source":"Silicon Republic","summary":"Dr Ivan Coulter: ‘Raising funds is like hunting a moving target’ - Silicon Republic","headline":"Dr Ivan Coulter: ‘Raising funds is like hunting a moving target’","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}